Latest filing published 14 Jul 2023 for Cano Health, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Marlow Hernandez: trading record in brief
Marlow Hernandez (chief executive) discloses dealings in Cano Health, Inc. to SEC (Form 4). We count 30 filings; the first trade dates from 16 August 2021 and the latest from 12 July 2023.
The open-market record is one-sided, with 19 purchases worth €14.7M and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 9 share grants.
The median purchase comes to €97k. On 13 out of 17 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
On 14 July 2023 came the latest disclosure, a share grant in Cano Health, Inc. The last purchase on record was published on 7 December 2021, which is 1,798 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Marlow Hernandez
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 189,681 sharesClass A Common StockSEC:0001209191-23-042327:0
- 671,742 sharesClass A Common StockSEC:0000950170-23-026059:0
- 348,604 sharesClass A Common StockSEC:0000899243-23-010565:0
- 134,660 shares@ US$0.8671.7% of flowClass A Common StockSEC:0000899243-23-000963:0
- 11,017,311 shares0Class A Common StockSEC:0000899243-22-039535:0
- 29,870 shares@ US$3.521.6% of flowClass A Common StockSEC:0000899243-22-025682:0
- 11,017,311 shares0Class A Common StockSEC:0000899243-22-020172:0
- 624,418 sharesClass A Common StockSEC:0000899243-22-011466:0
- 15,000 shares@ US$8.004.8% of flowClass A Common StockSEC:0000899243-21-047185:0Canonical exit: 6 Mar 2022 (T+90)
- 12,500 shares@ US$8.754.3% of flowClass A Common StockSEC:0000899243-21-046941:0Canonical exit: 3 Mar 2022 (T+90)
- 8,000 shares@ US$9.653.1% of flowClass A Common StockSEC:0000899243-21-046067:0Canonical exit: 20 Feb 2022 (T+90)
- 1,339,500 sharesClass A Common StockSEC:0000899243-21-037547:0
- 5,833 shares@ US$11.992.7% of flowClass A Common StockSEC:0000899243-21-034907:0Canonical exit: 29 Nov 2021 (T+90)
- 54,727 shares@ US$11.9324.8% of flowClass A Common StockSEC:0000899243-21-034612:0Canonical exit: 23 Nov 2021 (T+90)
- 120,000 shares@ US$10.1616.9% of flowClass A Common StockSEC:0000899243-21-033876:0Canonical exit: 14 Nov 2021 (T+90)
- 11,900 shares@ US$9.824.5% of flowClass A Common StockSEC:0000899243-21-033963:0Canonical exit: 16 Nov 2021 (T+90)
- 120,000 shares@ US$10.1646.4% of flowClass A Common StockSEC:0000899243-21-033441:0
17 of 17 declarations